Use of Atosiban in in Vitro Fertilization (IVF) Treatment
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this randomized double blind study is that the live birth rates are
significantly higher after the use of atosiban prior to the embryo transfer in patients
undergoing in vitro fertilization (IVF) treatment. This study aims to compare the live birth
rates of IVF treatment between patients receiving atosiban and placebo prior to the transfer.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Hong Kong
Collaborators:
Nanfang Hospital of Southern Medical University Vietnam National University